Sifuvirtide

Medical Advocates
Sifuvirtide

Main Page

New and Noteworthy
Journal Abstracts, Papers, and Commentaries

ARV Investigational Drugs

Main New/Noteworthy

Home Page

Last Update: January 15, 2012
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

January 2012

A WEEK-IN REVIEW FEATURED REPORT
Broad antiviral activity and crystal structure of HIV-1 fusion inhibitor Sifuvirtide.
Yao X, Chong H, Zhang C J Biol Chem. 2012 Jan 6.

Journal Papers, Abstracts, and Commentaries

A WEEK-IN REVIEW FEATURED REPORT
Broad antiviral activity and crystal structure of HIV-1 fusion inhibitor Sifuvirtide.
Yao X, Chong H, Zhang C
J Biol Chem. 2012 Jan 6.
Abstract

The role of blood cell membrane lipids on the mode of action of HIV-1 fusion inhibitor sifuvirtide.
Matos PM, Freitas T, Castanho MA, Santos NC.
Biochem Biophys Res Commun. 2010 Nov 12
Abstract

An improved on-line solid phase extraction coupled HPLC-MS/MS system for quantification of sifuvirtide in human plasma.
Wang QQ, Xiang SS, Jia YB. et al
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jul 1;878(21):1893-8
Abstract

Unravelling the molecular basis of the selectivity of the HIV-1 fusion inhibitor sifuvirtide towards phosphatidylcholine-rich rigid membranes.
Franquelim HG, Veiga AS, Weissmüller G, et al
Biochim Biophys Acta. 2010 Jun;1798(6):1234-43
Abstract

Sifuvirtide, a potent HIV fusion inhibitor peptide.
Wang RR, Yang LM, Wang YH, et al
Biochem Biophys Res Commun. 2009 Mar 13
Abstract

ARV Investigational Drugs

Main New/Noteworthy

Home Page

Sifuvirtide